OpenBilldrug price receipt

NADAC week of 2026-10-14

STIOLTO RESPIMAT INHALER (60)

FDA nonproprietary name: tiotropium bromide and olodaterol

For 1 g

Pharmacies pay

$115.80 filed

1 × $115.80015 per GM

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$113.32 filed

1 × $113.31549 per GM, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.98× estimated

Medicare paid about what pharmacies pay.

Part D averages every strength and form sold under “Stiolto Respimat” / “Tiotropium Br/Olodaterol HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$138.17 estimated

$115.80 + $17.37 (15%) + $5.00 fee per fill = $138.17

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

STIOLTO RESPIMAT INHALER (60) is how the CMS NADAC file names this product. The FDA NDC Directory lists it as tiotropium bromide and olodaterol, under the trade name “Stiolto Respimat”.

FDA gives its dosage form as spray, metered and its route as respiratory (inhalation).

The labeler, the company named on the label, is Boehringer Ingelheim Pharmaceuticals, Inc.

FDA lists it under 2 Established Pharmacologic Classes: Anticholinergic and beta2-Adrenergic Agonist.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 00597-0155-61.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $115.80 for 1 g (1 × $115.80015 per GM, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

The NDC

Compared with its class

Its NADAC price is $115.80015 per GM filed.

Of the 7 other products in FDA’s Anticholinergic class priced per GM, 3 have a higher middle NADAC price and 4 a lower one. The one in the middle is BREZTRI AEROSPHERE 160-9-4.8 MCG, at $61.30387 per GM filed (eff. 2026-09-23).

Of the 24 other products in FDA’s beta2-Adrenergic Agonist class priced per GM, 1 has a higher middle NADAC price and 23 a lower one. The one in the middle is FLUTICASONE-SALMETEROL 115-21, at $20.70767 per GM filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $113.32 for 1 g, at an average of $113.31549 per GM in 2024 (2024-01-01 to 2024-12-31) for “Stiolto Respimat” and “Tiotropium Br/Olodaterol HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 695,441 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for STIOLTO RESPIMAT INHALER (60) labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Stiolto Respimat / Tiotropium Br/Olodaterol HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's GM. Joined on brand name.
Why does this page start at 1 g?
The FDA package description of NDC 00597-0155-61 (“1 CARTRIDGE in 1 CARTON (0597-0155-61) / 60 SPRAY, METERED in 1 CARTRIDGE”) does not give one amount in g, NADAC’s unit for this product. So the card starts at 1 GM; change it to match your prescription.